» Authors » Stephan Segerer

Stephan Segerer

Explore the profile of Stephan Segerer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 2981
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Kitterer D, Segerer S, Braun N, Alscher M, Latus J
Kidney Blood Press Res . 2017 May; 42(2):276-283. PMID: 28531889
Background/aims: Gender-specific differences between patients on renal replacement therapy have so far rarely been investigated. In the present study we aimed to describe gender-specific differences in a large cohort of...
32.
Kitterer D, Braun N, Alscher M, Segerer S, Latus J
Int J Nephrol Renovasc Dis . 2016 Aug; 9:183-6. PMID: 27540308
Background: Encapsulating peritoneal sclerosis (EPS) is the most severe complication associated with long-term peritoneal dialysis (PD). Previous studies noticed a sharp decline in new patients with severe EPS. We investigated...
33.
Kitterer D, Segerer S, Dippon J, Alscher M, Braun N, Latus J
Nephron . 2016 Jul; 134(2):89-94. PMID: 27388481
Background/aims: Hantaviruses are zoonotic pathogens causing emerging diseases worldwide. Patients typically present with fever, acute kidney injury (AKI) and thrombocytopenia. Puumala virus (PUUV) that causes nephropathia epidemica (NE) is common...
34.
Kitterer D, Greulich S, Grun S, Segerer S, Mustonen J, Alscher M, et al.
Eur J Intern Med . 2016 Jun; 33:67-73. PMID: 27296590
Background: Nephropathia epidemica (NE), caused by Puumala virus (PUUV), is characterized by acute kidney injury (AKI) and thrombocytopenia. Cardiac involvement with electrocardiographic (ECG) abnormalities has been previously reported in NE;...
35.
Segerer S, Sugano Y, Lindenmeyer M, Auberger I, Ziegler U, Cohen C, et al.
Kidney Int . 2016 Apr; 89(5):1161-1162. PMID: 27083290
No abstract available.
36.
Thalhammer C, Clemens R, Valentin M, Alonso E, Segerer S, Husmann M, et al.
Vasa . 2016 Apr; 45(2):163-8. PMID: 27058803
Background: Increased flow in the subclavian artery feeding a vascular access for hemodialysis can induce steal phenomena in the vertebral (VA) and internal mammary artery (IMA). The aim of this...
37.
Kraus A, Chen J, Edenhofer I, Ravens I, Gaspert A, Cippa P, et al.
PLoS One . 2016 Feb; 11(2):e0147951. PMID: 26840537
DNAX accessory protein-1 (DNAM-1, CD226) is a co-stimulatory and adhesion molecule expressed mainly by natural killer cells and T cells. DNAM-1 and its two ligands CD112 and CD155 are important...
38.
Riwanto M, Kapoor S, Rodriguez D, Edenhofer I, Segerer S, Wuthrich R
PLoS One . 2016 Jan; 11(1):e0146654. PMID: 26752072
Dysregulated signaling cascades alter energy metabolism and promote cell proliferation and cyst expansion in polycystic kidney disease (PKD). Here we tested whether metabolic reprogramming towards aerobic glycolysis ("Warburg effect") plays...
39.
Rodriguez D, Kapoor S, Edenhofer I, Segerer S, Riwanto M, Kipar A, et al.
Kidney Blood Press Res . 2015 Dec; 40(6):638-47. PMID: 26698317
Background/aims: Dapagliflozin (DAPA) is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) which induces glucosuria and osmotic diuresis. The therapeutic effect of DAPA in progressing stages of polycystic kidney...
40.
Prange J, Bieri M, Segerer S, Burger C, Kaech A, Moritz W, et al.
Pflugers Arch . 2015 Dec; 468(4):739-50. PMID: 26676951
The epithelial cells lining the proximal tubules of the kidney mediate complex transport processes and are particularly vulnerable to drug toxicity. Drug toxicity studies are classically based on two-dimensional cultures...